VANI · Vivani Medical, Inc.
$1.26
-0.05 (-3.82%)
At close · Jul 29
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our ability to continue as a going concern beyond the second quarter of 2027 is dependent on our ability to raise additional capital, however, and there can be no assurances that we will be able to do so.”View the 10-Q filed May 13, 2026
Market Cap
$108.66M
Shares
86.24M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Adam Mendelsohn | CEO | $877,580 |
| Truc Le | COO | $696,864 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Adam Mendelsohn | CEO | $1,084,200 |
| Truc Le | COO | $862,600 |
| Lisa Porter | Chief Medical Officer | $678,200 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Adam Mendelsohn | CEO | $1,044,621 |
| Lisa Porter | Chief Medical Officer | $661,533 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Scott Dunbar | CEO | $382,153 |
| Truc Le | COO | $337,200 |
| Adam Mendelsohn | CEO | $312,014 |
| Brigid A. Makes | CFO | $306,009 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Truc Le | COO | $552,674 |
| Adam Mendelsohn | CEO | $308,300 |
| Scott Dunbar | CEO | $305,685 |